We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Halozyme Therapeutics Incorporated | NASDAQ:HALO | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.42 | 1.09% | 38.88 | 37.13 | 42.20 | 39.02 | 38.44 | 38.46 | 547,134 | 23:04:16 |
|
Date of Report (Date of Earliest Event Reported):
|
|
May 2, 2019
|
Delaware
|
|
001-32335
|
|
88-0488686
|
(State or other jurisdiction of incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer Identification No.)
|
|
|
|
|
|
11388 Sorrento Valley Road, San Diego, California
|
|
92121
|
||
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrant’s telephone number, including area code:
|
|
858-794-8889
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, $0.001 par value
|
HALO
|
The Nasdaq Stock Market LLC
|
|
Names
|
|
Votes For
|
|
Withheld
|
|
Broker Non-Votes
|
Jeffrey W. Henderson
|
|
101,090,907
|
|
1,310,664
|
|
23,381,529
|
Connie L. Matsui
|
|
100,720,626
|
|
1,680,945
|
|
23,381,529
|
Helen I. Torley
|
|
101,785,053
|
|
616,518
|
|
23,381,529
|
Votes For
|
|
Votes Against
|
|
Abstain
|
|
Broker Non-Votes
|
92,074,144
|
|
10,263,491
|
|
63,936
|
|
23,381,529
|
Votes For
|
|
Votes Against
|
|
Abstain
|
|
Broker Non-Votes
|
125,054,022
|
|
657,474
|
|
71,604
|
|
—
|
Votes For
|
|
Votes Against
|
|
Abstain
|
|
Broker Non-Votes
|
111,437,037
|
|
14,088,195
|
|
257,868
|
|
—
|
|
||
|
|
|
Exhibit No.
|
|
Description
|
|
Amended and Restated Certificate of Incorporation of Halozyme Therapeutics, Inc.
|
|
|
HALOZYME THERAPEUTICS, INC.
|
||
|
|
|
|
|
May 3, 2019
|
|
By:
|
|
/s/ Harry J. Leonhardt, Esq.
|
|
|
|
|
|
|
|
Name:
|
|
Harry J. Leonhardt, Esq.
|
|
|
Title:
|
|
Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary
|
1 Year Halozyme Therapeutics Chart |
1 Month Halozyme Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions